Registration Dossier

Diss Factsheets

Toxicological information

Repeated dose toxicity: oral

Currently viewing:

Administrative data

Endpoint:
sub-chronic toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)

Data source

Referenceopen allclose all

Reference Type:
study report
Title:
Unnamed
Year:
1979
Reference Type:
secondary source
Title:
BUA Stoffbericht 55: Chlortoluidine (3-Chlor-2-methylanilin, 5-Chlor-2-methylanilin, 3-Chlor-4-methylanilin)
Author:
BUA Beratergremium für umweltrelevante Altstoffe
Year:
1990
Bibliographic source:
Verlag Chemie Weinheim 1991

Materials and methods

Test guideline
Guideline:
other: no data
Principles of method if other than guideline:
see BUA Stoffberichte No. 55 for details
GLP compliance:
not specified

Test material

Constituent 1
Chemical structure
Reference substance name:
5-chloro-o-toluidine
EC Number:
202-452-6
EC Name:
5-chloro-o-toluidine
Cas Number:
95-79-4
Molecular formula:
C7H8ClN
IUPAC Name:
5-chloro-2-methylaniline

Test animals

Species:
rat
Strain:
Fischer 344
Sex:
male/female

Administration / exposure

Route of administration:
oral: feed
Vehicle:
not specified
Analytical verification of doses or concentrations:
not specified
Duration of treatment / exposure:
4 weeks
Frequency of treatment:
no data
Doses / concentrationsopen allclose all
Remarks:
Doses / Concentrations:
31.5 mg/kg BW
Basis:
nominal in diet
Remarks:
Doses / Concentrations:
68 mg/kg BW
Basis:
nominal in diet
Remarks:
Doses / Concentrations:
146.5 mg/kg BW
Basis:
nominal in diet
Remarks:
Doses / Concentrations:
315.5 mg/kg BW
Basis:
nominal in diet
Remarks:
Doses / Concentrations:
680 mg/kg BW
Basis:
nominal in diet
No. of animals per sex per dose:
5

Results and discussion

Results of examinations

Clinical signs:
no effects observed
Description (incidence and severity):
No mortallity. 100 % of the animals survived.
Mortality:
no mortality observed
Description (incidence):
No mortallity. 100 % of the animals survived.
Body weight and weight changes:
effects observed, treatment-related
Description (incidence and severity):
reduced weight increase rate
Food consumption and compound intake (if feeding study):
not specified
Food efficiency:
not specified
Water consumption and compound intake (if drinking water study):
not specified
Ophthalmological findings:
not specified
Haematological findings:
not specified
Clinical biochemistry findings:
not specified
Urinalysis findings:
not specified
Behaviour (functional findings):
not specified
Organ weight findings including organ / body weight ratios:
not specified
Gross pathological findings:
effects observed, treatment-related
Description (incidence and severity):
speckled liver and kidneys even at lowest concentration
Histopathological findings: non-neoplastic:
no effects observed
Histopathological findings: neoplastic:
no effects observed

Effect levels

Remarks on result:
not measured/tested
Remarks:
Effect level not specified (migrated information)

Target system / organ toxicity

Critical effects observed:
not specified

Any other information on results incl. tables

The study was conducted as a preliminary test to determine the optimal dosage for a chronic toxicity study. Therefore no effect level is available.

Applicant's summary and conclusion